enVVeno Medical Corp financial data

Symbol
NVNO on Nasdaq, NVNBW on OTC
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1639% % -38%
Debt-to-equity 8% % 34%
Return On Equity -61% % -26%
Return On Assets -57% % -24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20,216,176 shares 15%
Common Stock, Shares, Outstanding 20,216,000 shares 15%
Entity Public Float $68,900,000 USD 136%
Weighted Average Number of Shares Outstanding, Basic 20,155,000 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 20,155,000 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $11,546,000 USD -1.4%
Operating Income (Loss) $23,585,000 USD -0.77%
Nonoperating Income (Expense) $1,620,000 USD -25%
Net Income (Loss) Attributable to Parent $21,965,000 USD -3.4%
Earnings Per Share, Basic -1 USD/shares 16%
Earnings Per Share, Diluted -1 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,544,000 USD -91%
Assets, Current $31,499,000 USD -36%
Property, Plant and Equipment, Net $82,000 USD -62%
Operating Lease, Right-of-Use Asset $740,000 USD -32%
Assets $32,352,000 USD -36%
Liabilities, Current $2,400,000 USD 7.7%
Operating Lease, Liability, Noncurrent $505,000 USD -36%
Liabilities $2,905,000 USD -3.8%
Retained Earnings (Accumulated Deficit) $167,591,000 USD -15%
Stockholders' Equity Attributable to Parent $29,447,000 USD -38%
Liabilities and Equity $32,352,000 USD -36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,018,000 USD -13%
Net Cash Provided by (Used in) Financing Activities $46,000 USD
Net Cash Provided by (Used in) Investing Activities $5,201,000 USD 137%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 20,216,000 shares 15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,183,000 USD
Deferred Tax Assets, Gross $30,597,000 USD 20%
Operating Lease, Liability $1,064,000 USD -24%
Depreciation $100,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $10,000 USD 100%
Lessee, Operating Lease, Liability, to be Paid $1,125,000 USD -26%
Property, Plant and Equipment, Gross $1,439,000 USD 1.8%
Operating Lease, Liability, Current $286,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $411,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $399,000 USD 3.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $61,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Three $315,000 USD -23%
Deferred Tax Assets, Operating Loss Carryforwards $22,163,000 USD 29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $197,038,000 USD 2.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $30,315,000 USD 22%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%